Sun Pharma
Image -

Drug major Sun Pharmaceutical Industries on Monday said its Netherlands-based arm has fully acquired PJSC Biosintez, Russia by purchasing 3.04 per cent stake in the company under the mandatory tender offer.

The company’s subsidiary — Sun Pharma (Netherlands) BV — already had 96.96 per cent stake in pharma firm PJSC Biosintez prior to the purchase of these shares, Sun Pharma said in a filing to the BSE.

Post the purchase, Sun Pharma (Netherlands) BV’s shareholding in the target entity has increased from 96.96 per cent to 100 per cent, it added.

Cash consideration of Rubles 54,194,628.60 equivalent to USD 815,201.99 (about Rs 6 crore) was paid to shareholders who tendered their respective shares in the mandatory tender offer, Sun Pharma said.

Shares of Sun Pharmaceutical Industries on Monday closed at Rs 428.80 per scrip on the BSE, up 0.92 per cent from its previous close.

Like this content? Sign up for our daily newsletter to get latest updates.

RELATED READING  Reliance Acquires 3 Startups - Reverie, Easygov and SankhyaSutra Labs

Russian Cybersecurity Firm Kaspersky to Set Up Data Transparency Centre in India

Previous article

HCL Tech to Acquire Sankalp Semiconductor for US$25 Mn

Next article



This site uses Akismet to reduce spam. Learn how your comment data is processed.

You may also like